Quick Takeaways
- Andrew J. Fromkin has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $2,477,293.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Andrew J. Fromkin
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Andrew J. Fromkin is at least $2,477,293 dollars as of 09 Apr 2026. Andrew J. Fromkin is the Director of Immunovant, Inc. and owns shares of Immunovant, Inc. (IMVT) stock worth about $2.48M.
- Signature
- /s/ Tiago Girao, attorney-in-fact for Andrew J. Fromkin
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Andrew J. Fromkin and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Immunovant, Inc. ($2,477,293).
- Past-year value change for that position: -$517,189.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Andrew J. Fromkin
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | Director | $2,477,293 | -$517,189 | -17% | 07 Apr 2026 |
Insider Transactions Reported by Andrew J. Fromkin:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.